These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19445682)

  • 1. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.
    Park S; Cho GY; Kim SG; Hwang YI; Kang HR; Jang SH; Kim DG; Song YR; Bae YA; Jung KS
    Crit Care; 2009; 13(3):R70. PubMed ID: 19445682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
    Hayashi T; Yasuda K; Kimura T; Sasaki K; Shimada K; Hashimoto N; Isaka Y
    Am J Nephrol; 2018; 48(3):205-213. PubMed ID: 30196305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
    Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: A Cohort Study.
    Oka T; Sakaguchi Y; Hattori K; Asahina Y; Kajimoto S; McCallum W; Tighiouart H; Sarnak MJ; Kaimori JY; Isaka Y
    Am J Kidney Dis; 2023 Nov; 82(5):559-568. PubMed ID: 37354935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
    PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
    Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
    Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
    Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
    Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.
    Di Somma S; Magrini L; Pittoni V; Marino R; Mastrantuono A; Ferri E; Ballarino P; Semplicini A; Bertazzoni G; Carpinteri G; Mulè P; Pazzaglia M; Shah K; Maisel A; Clopton P
    Crit Care; 2010; 14(3):R116. PubMed ID: 20550660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients.
    Kadri AN; Kaw R; Al-Khadra Y; Abuamsha H; Ravakhah K; Hernandez AV; Tang WHW
    Arch Med Sci; 2018 Aug; 14(5):1003-1009. PubMed ID: 30154881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
    Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
    J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
    Shah KB; Kop WJ; Christenson RH; Diercks DB; Kuo D; Henderson S; Hanson K; Mehra MR; deFilippi CR
    Clin Chem; 2009 Jan; 55(1):59-67. PubMed ID: 18988754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
    Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.